Policy Guidance on Drug-Susceptibility Testing (DST) of Second-Line Antituberculosis Drugs

Policy Guidance on Drug-Susceptibility Testing (DST) of Second-Line Antituberculosis Drugs

Book. 2008

Authors: Barrera L, Cooreman E, de Dieu Iragena J, Drobniewski F, Duda P, Havelkova M, Hoffner S, Kam KM, Kim SJ, Labelle S, Lambregts K, Leimane V, Nunn P, Ramsay A, Raviglione M, Rich M, Ridderhof J, Rodrigues F, Rüsch-Gerdes S, Salfinger M, Scholten J, Selvakumar N, Shinnick T, Shul'gina M, Šķenders G, Sloutsky A, Small P, Van Deun A, Varaine F, Yagui M, Vincent V, Weyer K, Wright A, Zignol M

Abstract
This document is intended to provide an interim policy framework for the laboratory component relevant to programmatic implementation of MDR-TB strategies. A detailed technical manual on laboratory methodology, laboratory biosafety and standard operating procedures related to second-line drug-susceptibility testing (DST) is also under preparation.


PMID: 26290924